PE Anti-Whitlow/218 Linker Antibody

Product Details


Clone1B4A1
ApplicationFlow Cytometry
ReactivityWhitlow/218 Linker
FormatPE
Target NameWhitlow/218 linker, Whitlow 218 linker
IsotypeRabbit IgG
Antibody TypeMonoclonal
Regulatory StatusRUO
FormulationPhosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and 0.2% (w/v) BSA
Protein ConcentrationSupplied at a lot-specific concentration.
Storage & HandlingThe antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Recommended UsageFor flow cytometric staining, it is recommended to use 5 μL of this reagent per 0.5-1.0 million cells in a 100 µL volume. Optimal reagent performance should be determined by titration for each specific application.
Excitation LaserBlue Laser (488 nm) Green/Yellow laser (532/561nm)
See All FormatsClone 1B4A1

Background Information


Anti-Whitlow/218 Linker Antibody is an antibody designed to recognize the synthetic Whitlow/218 peptide sequence used as a linker between the variable heavy (VH) and variable light (VL) domains of single-chain variable fragments (scFvs). Because this linker is incorporated into many scFv-based chimeric antigen receptors (CARs), anti-Whitlow/218 antibodies provide a broadly applicable method for detecting CARs independently of their antigen specificity. The Whitlow/218 linker has been reported to improve resistance to proteolysis and aggregation within scFv structures.

Structurally, the Whitlow/218 linker is a flexible synthetic peptide; one commonly reported sequence is GSTSGSGKPGSGEGSTKG. It connects VH and VL domains and helps maintain the proper organization and flexibility of the CAR's extracellular antigen-binding domain. Anti-Whitlow/218 antibodies recognize epitopes within this linker sequence. Commercial monoclonal antibodies have been validated for flow cytometric detection of cell-surface CARs containing the linker.

The Whitlow/218 linker itself has no physiological ligand or receptor because it is an engineered sequence. Consequently, anti-Whitlow/218 antibodies do not have a conventional disease-associated target and are not themselves therapeutic agents. Their principal role is analytical, including detection and quantification of CAR-expressing cells by flow cytometry, immunofluorescence, and related assays. Recent studies demonstrated that anti-Whitlow/218 antibodies can detect CAR-T cells directed against different targets, including CD19 and BCMA.

In CAR-T therapy, anti-Whitlow/218 antibodies can support manufacturing quality control, characterization of engineered cells, and longitudinal monitoring of CAR-T-cell expansion and persistence. Because the antibody recognizes a common structural element rather than the CAR's target antigen, the same detection reagent can potentially be applied across multiple CAR designs containing the Whitlow/218 linker. This makes anti-Whitlow/218 antibodies useful research and clinical-monitoring tools for CAR-T-cell development and immune-cell therapy.

Isotype Control


APC Rabbit IgG, κ2 Isotype Control (Fc silent) Antibody

Data Sheets


PE Anti-Whitlow/218 Linker Antibody TDS

Related Protocols


Flow Cytometry Protocol


Have a product or application question? Consult our FAQs or contact us.